Net Income

With a new outpatient model, NexCure aims to bring life-saving cancer treatments like CAR-T closer to home, tackling a major healthcare bottleneck.

Investors eye Moody's CEO Rob Fauber's upcoming speech for insights on AI strategy, M&A forecasts, and navigating an increasingly complex global economy.

Struggling manufacturer Highway Holdings acquires a 51% stake in Germany's Regent-Feinbau, a bold move to enter high-value markets and build resilient supply chains.

With mixed trial results for its obesity drug and rising costs, Skye Bioscience's upcoming 2025 earnings call is a pivotal moment for investors.

Kura Oncology's new AML drug, KOMZIFTI, sees rapid market uptake, strong financials, and an ambitious plan to reshape targeted cancer therapy.

Biotech firm Immunis, Inc. secures a promising drug candidate to treat a debilitating side effect of Parkinson's therapy, offering hope to millions.

Houston's largest credit union wins its second Gallup award in three years. We explore the strategy connecting happy employees to a thriving bottom line.

Ad-tech giant Teads reports massive revenue growth post-merger, but a $352M impairment and restructuring signal deep integration challenges.

The Geneva Association recognizes Elena Sanz for her exceptional leadership, blending a human-focused strategy with decisive action during recent crises.

Following key acquisitions, the AI firm pivots to a vertically integrated defense powerhouse, forecasting explosive growth backed by a swelling order backlog.

Royal Caribbean and its new ships claim top honors in the 2026 Cruiseline.com awards, revealing how passenger-driven reviews are shaping the industry.

A Chinese firm's win at a top Korean battery expo signals a major shift in manufacturing tech, accelerating the path to cheaper, greener, solid-state batteries.

ST's new STM32C5 microcontroller series promises to bring high-end performance and robust security to billions of cost-sensitive smart devices.

A new global survey reveals the crushing mental burden of diabetes, sparking a call for AI-powered tools that promise to restore spontaneity and control.

German defense tech firm RENK Group reports a record €1.37B revenue, fueled by a 24% surge in its defense business amid global geopolitical tensions.

Record sales of its Trio® fertilizer fuel a major financial turnaround, as the company makes significant strides in extracting battery-grade lithium.

The company narrows losses and sells a major asset, betting on experiential attractions like the Balloon Museum to revitalize NYC's Seaport district.

Backed by Nobel-winning science and French state support, Pasqal's move to go public validates the commercial promise of deep quantum technology.

OmniAb reported declining revenue and a wider net loss for 2025, even as it launched its revolutionary OmniUltra platform and its partners' drugs advance.

Despite a tough 2025, Janus International's Q4 profit jump and 2026 growth forecast signal a strategic pivot driven by smart tech and a key acquisition.